Rad-Band is applied topically and is indicated for
the control of surface bleeding from vascular access sites and percutaneous catheters or tubes.
Rad-Band is contraindicated in persons with known sensitivity to
BLEEDING AND THROMBOSIS COMPLICATIONS
- THROMBIN-JMI® can cause fatal severe bleeding or thrombosis. Thrombosis may
result from the development of antibodies against bovine thrombin. Bleeding may result from the
development of antibodies against factor V. These may cross-react with human factor V and lead to
- Do not re-expose patients to THROMBIN-JMI® if there are known or suspected
antibodies to bovine thrombin and/or factor V.
- Monitor patients for abnormal coagulation laboratory values, bleeding, or thrombosis.
Refer to the Instructions for Use for a complete listing of the indications, contraindications,
warnings and precautions. Information in this material is not a substitute for the product
Instructions for Use.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Not all products are available in all regions. Please contact customer service to confirm
availability in your region.
THROMBIN-JMI is a registered trademark of King Pharmaceuticals Research and Development, LLC.
Teleflex, the Teleflex logo and D-Stat are trademarks or registered trademarks of Teleflex
Incorporated or its affiliates, in the U.S. and/or other countries. MC-004254 Rev 0